Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 5 Statistical Analysis of the Improvement in Rank

From: Indirect two-sided relative ranking: a robust similarity measure for gene expression data

Therapeutic Use N Mean Improvement StdDev tValue P
analgesic 29 90.43 117.55 4.14 0.0003
anti-inflammatory 160 30.12 115.04 3.31 0.0011
anti-psychotic (neurole) 69 25.57 73.36 2.90 0.0051
immunosuppressive agent 67 7.96 40.42 1.61 0.1120
tranquilizer 68 14.43 73.95 1.61 0.1124
cardiovascular agent 22 10.82 69.37 0.73 0.4726
anti-neoplastic 54 10.33 114.65 0.66 0.5106
anti-convulsant 144 -4.50 92.09 -0.59 0.5585
anti-proliferative 86 -1.86 77.86 -0.22 0.8252
  1. A paired t-test was performed to analyze the difference in the rank of true positives returned by the direct and indirect method. N is the number of true positives found within the top 100 results across the whole therapeutic group. Improvement is the average improvement (rank direct - rank indirect).